InvestorsHub Logo
Followers 5
Posts 1266
Boards Moderated 0
Alias Born 09/03/2002

Re: Sugarshaker post# 21640

Saturday, 08/19/2017 12:44:17 PM

Saturday, August 19, 2017 12:44:17 PM

Post# of 34575
Report on TPIV 200 in combination with AstraZeneca's durvalumab value will not be substantiated. All the other milestones put together will not add any actual value.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News